The expression of the immune-stimulatory molecule showed tumor specific cytotoxic effects in different mouse models of CD40+-CD19+ B-cells and patient-derived chronic lymphocytic leukemia cells (212). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.